Biotechnology Assets S.A. (BST) - Total Liabilities

Latest as of June 2025: €7.01 Million EUR ≈ $8.19 Million USD

Based on the latest financial reports, Biotechnology Assets S.A. (BST) has total liabilities worth €7.01 Million EUR (≈ $8.19 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Biotechnology Assets S.A. - Total Liabilities Trend (2010–2024)

This chart illustrates how Biotechnology Assets S.A.'s total liabilities have evolved over time, based on quarterly financial data. See BST working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Biotechnology Assets S.A. Competitors by Total Liabilities

The table below lists competitors of Biotechnology Assets S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
Opthea Ltd AU:OPT	Australia	AU$256.70 Million
Asia Seed Co.Ltd KQ:154030	Korea	₩16.44 Billion
COCRYSTAL PHARMA NEW O.N. F:8CC	Germany	€3.38 Million
CAM Resources Bhd KLSE:7128	Malaysia	RM39.40 Million
Prochem S.A. WAR:PRM	Poland	zł90.55 Million
Schroder Asia Pacific Fund LSE:SDP	UK	GBX44.96 Million
Accent Resources NL AU:ACS	Australia	AU$22.86 Million
Volt Carbon Technologies Inc V:VCT	Canada	CA$1.62 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Biotechnology Assets S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Biotechnology Assets S.A. (BST) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotechnology Assets S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotechnology Assets S.A. (2010–2024)

The table below shows the annual total liabilities of Biotechnology Assets S.A. from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	€8.17 Million ≈ $9.56 Million	-18.87%
2023-12-31	€10.08 Million ≈ $11.78 Million	-30.99%
2022-12-31	€14.60 Million ≈ $17.07 Million	-6.02%
2021-12-31	€15.54 Million ≈ $18.16 Million	-5.08%
2020-12-31	€16.37 Million ≈ $19.14 Million	-80.77%
2019-12-31	€85.11 Million ≈ $99.50 Million	+46.62%
2018-12-31	€58.04 Million ≈ $67.86 Million	+507.37%
2017-12-31	€9.56 Million ≈ $11.17 Million	+19.22%
2016-12-31	€8.02 Million ≈ $9.37 Million	+10.90%
2015-12-31	€7.23 Million ≈ $8.45 Million	+3.17%
2014-12-31	€7.01 Million ≈ $8.19 Million	+40.00%
2013-12-31	€5.00 Million ≈ $5.85 Million	+5.20%
2012-12-31	€4.76 Million ≈ $5.56 Million	+1.37%
2011-12-31	€4.69 Million ≈ $5.49 Million	+65.30%
2010-12-31	€2.84 Million ≈ $3.32 Million	--

About Biotechnology Assets S.A.

MC:BST Spain Biotechnology

Market Cap

$20.36 Million

€17.41 Million EUR

Market Cap Rank

#26282 Global

#197 in Spain

Share Price

€0.24

Change (1 day)

-0.41%

52-Week Range

€0.18 - €0.46

All Time High

€3.31